This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Roles Played by YY1 in Embryonic, Adult and Cancer Stem Cells
Stem Cell Reviews and Reports Open Access 17 March 2021
-
Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma
Scientific Reports Open Access 28 April 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645–648.
Bonnet D, Dick JE . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730–737.
Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ . Efficient tumor formation by single melanoma cells. Nature 2008; 456: 593–598.
Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010; 466: 133–137.
Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 2010; 18: 510–523.
Ishizawa K, Rasheed ZA, Karisch R, Wang Q, Kowalski J, Susky E et al. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 2010; 7: 279–282.
Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Ridler C, Lillington D et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 2008; 112: 568–575.
Sanchez PV, Perry RL, Sarry JE, Perl AE, Murphy K, Swider CR et al. A robust xenotransplantation model for acute myeloid leukemia. Leukemia 2009; 23: 2109–2117.
Sarry JE, Murphy K, Perry R, Sanchez PV, Secreto A, Keefer C et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rãc-deficient mice. J Clin Invest 2011; 121: 384–395.
Agliano A, Martin-Padura I, Mancuso P, Marighetti P, Rabascio C, Pruneri G et al. Human acute leukemia cells injected in NOD/LtSz-scid/IL2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid related strains. Int J Cancer 2008; 123: 2222–2227.
Pearce DJ, Taussig D, Zibara K, Smith LL, Ridler CM, Preudhomme C et al. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. Blood 2006; 107: 1166–1173.
Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009; 138: 271–285.
Van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S et al. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res 2005; 11: 6520–6527.
Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Sharrock K, Luke T et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34 (−) fraction. Blood 2010; 115: 1976–1984.
Wunderlich M, Chou FS, Link KA, Mizukawa B, Perry RL, Carroll M et al. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia 2010; 24: 1785–1788.
Acknowledgements
We are indebted to patients who gave samples. We would like to acknowledge Dr Jude Fitzgibbon for critical reviewing of the article. Authors are grateful to the Animal Care Facility staff members for their valuable technical help. We thank Dr Finlay Mac Dougall for providing diagnostic information. DCT is supported by a Medical Research Council Clinician Scientist Fellowship. This work was supported by Cancer Research UK (DB and JGG) and by European grant (contract No. 037632) to DB.
Author contributions
JV and DCT designed and performed research, analyzed and interpreted data; EG and FAA performed research, analyzed and interpreted data; TAL, HO and JC provided vital materials and data; JGG provided vital materials and critical review of the manuscript; and DB designed research, analyzed and interpreted data and wrote manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Vargaftig, J., Taussig, D., Griessinger, E. et al. Frequency of leukemic initiating cells does not depend on the xenotransplantation model used. Leukemia 26, 858–860 (2012). https://doi.org/10.1038/leu.2011.250
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.250
This article is cited by
-
Roles Played by YY1 in Embryonic, Adult and Cancer Stem Cells
Stem Cell Reviews and Reports (2021)
-
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
Nature Reviews Cancer (2020)
-
Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model
Leukemia (2016)
-
Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma
Scientific Reports (2016)
-
Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia
Leukemia (2014)